
### [MONDO:0017144](http://purl.obolibrary.org/obo/MONDO_0017144)
**Label:** alpha-thalassemia and related diseases

**Subclasses:** [MONDO:0010519](http://purl.obolibrary.org/obo/MONDO_0010519) (alpha thalassemia-X-linked intellectual disability syndrome), [MONDO:0016513](http://purl.obolibrary.org/obo/MONDO_0016513) (alpha-thalassemia-related diseases), [MONDO:0011399](http://purl.obolibrary.org/obo/MONDO_0011399) (alpha thalassemia), [MONDO:0007716](http://purl.obolibrary.org/obo/MONDO_0007716) (alpha thalassemia-intellectual disability syndrome type 1), [MONDO:0013512](http://purl.obolibrary.org/obo/MONDO_0013512) (hemoglobin H disease), [MONDO:0015579](http://purl.obolibrary.org/obo/MONDO_0015579) (Hb Bart's hydrops fetalis), [MONDO:0010328](http://purl.obolibrary.org/obo/MONDO_0010328) (alpha-thalassemia-myelodysplastic syndrome), 

**Mapped go classes:** [GO:0019825](http://purl.obolibrary.org/obo/GO_0019825) (oxygen binding), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0015671](http://purl.obolibrary.org/obo/GO_0015671) (oxygen transport), [GO:0030492](http://purl.obolibrary.org/obo/GO_0030492) (hemoglobin binding), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0005344](http://purl.obolibrary.org/obo/GO_0005344) (oxygen carrier activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0000784](http://purl.obolibrary.org/obo/GO_0000784) (nuclear chromosome, telomeric region), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0004601](http://purl.obolibrary.org/obo/GO_0004601) (peroxidase activity), [GO:0005833](http://purl.obolibrary.org/obo/GO_0005833) (hemoglobin complex), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0005506](http://purl.obolibrary.org/obo/GO_0005506) (iron ion binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0031838](http://purl.obolibrary.org/obo/GO_0031838) (haptoglobin-hemoglobin complex), [GO:0072562](http://purl.obolibrary.org/obo/GO_0072562) (blood microparticle), [GO:0031721](http://purl.obolibrary.org/obo/GO_0031721) (hemoglobin alpha binding), [GO:0031722](http://purl.obolibrary.org/obo/GO_0031722) (hemoglobin beta binding), [GO:0031720](http://purl.obolibrary.org/obo/GO_0031720) (haptoglobin binding), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 54.17%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 54.17%
- Thing 52.22%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 39.52%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039566](http://purl.obolibrary.org/obo/GO_0039566) (obsolete suppression by virus of host STAT1 activity by tyrosine dephosphorylation of STAT1)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039565](http://purl.obolibrary.org/obo/GO_0039565) (obsolete suppression by virus of host STAT1 activity by positive regulation of STAT1 catabolic process)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039561](http://purl.obolibrary.org/obo/GO_0039561) (obsolete suppression by virus of host IRF9 activity by positive regulation of IRF9 localization to nucleus)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039559](http://purl.obolibrary.org/obo/GO_0039559) (obsolete suppression by virus of host IRF7 activity by positive regulation of IRF7 catabolic process)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039558](http://purl.obolibrary.org/obo/GO_0039558) (obsolete suppression by virus of host IRF7 activity by positive regulation of IRF7 sumoylation)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039555](http://purl.obolibrary.org/obo/GO_0039555) (obsolete suppression by virus of host MDA-5 activity via MDA-5 binding)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039551](http://purl.obolibrary.org/obo/GO_0039551) (obsolete suppression by virus of host IRF3 activity by positive regulation of IRF3 catabolic process)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039550](http://purl.obolibrary.org/obo/GO_0039550) (obsolete suppression by virus of host IRF3 activity by inhibition of DNA binding)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039549](http://purl.obolibrary.org/obo/GO_0039549) (obsolete suppression by virus of host IRF3 activity by inhibition of IRF3 phosphorylation)) 39.52%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:0039546](http://purl.obolibrary.org/obo/GO_0039546) (obsolete suppression by virus of host MAVS activity by MAVS proteolysis)) 39.52%


